CCR9 Antibody (248621R) [Janelia Fluor® 525]
Novus Biologicals, part of Bio-Techne | Catalog # FAB1791RJF525
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry, Immunocytochemistry
Label
Janelia Fluor 525
Antibody Source
Recombinant Monoclonal Mouse IgG2A Clone # 248621R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human CCR9 transfectants
Met1-Leu369
Accession # P51686
Met1-Leu369
Accession # P51686
Specificity
Detects human CCR9 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for CCR9 Antibody (248621R) [Janelia Fluor® 525]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CCR9
Alternate Names
CCR9, CD199, CDw199
Additional CCR9 Products
Product Documents for CCR9 Antibody (248621R) [Janelia Fluor® 525]
Product Specific Notices for CCR9 Antibody (248621R) [Janelia Fluor® 525]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...